AUTHOR=San-Juan Daniel , Sarmiento Carlos Ignacio , Hernandez-Ruiz Axel , Elizondo-Zepeda Ernesto , Santos-Vázquez Gabriel , Reyes-Acevedo Gerardo , Zúñiga-Gazcón Héctor , Zamora-Jarquín Carol Marina TITLE=Transcranial Alternating Current Stimulation: A Potential Risk for Genetic Generalized Epilepsy Patients (Study Case) JOURNAL=Frontiers in Neurology VOLUME=Volume 7 - 2016 YEAR=2016 URL=https://www.frontiersin.org/journals/neurology/articles/10.3389/fneur.2016.00213 DOI=10.3389/fneur.2016.00213 ISSN=1664-2295 ABSTRACT=Transcranial alternating current stimulation (tACS) is a re-emergent neuromodulation technique that consists in the external application of oscillating electrical currents that induces changes in cortical excitability. We present the case of a 16-year-old female with pharmaco-resistant juvenile myoclonic epilepsy to three antiepileptic’s drugs characterized by four myoclonic and 20 absence seizures monthly. She received tACS at 1mA@3Hz pulse train during 60 minutes over Fp1-Fp2 (10-20 EEG international system position) during 4 consecutive days using an Endeavor™ IOM Systems device® (Natus Medical Incorporated, Middleton, WI, USA). At the one-month follow-up, she reported a 75% increase in seizures frequency (only myoclonic and tonic-clonic events) and developed a 24h myoclonic status epilepticus that resolved with oral clonazepam and intravenous valproate. At the two-month follow-up, the patient reported a 15-day seizure-free period.